Differential PIAS3 expression in human malignancy

Liming Wang1, Sipra Banerjee

  • 1Deptartment of Cancer Biology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. wangl@ccf.org

Oncology Reports
|May 13, 2004
PubMed

Insights

Protein inhibitor of activated STAT3 (PIAS3) regulates protein stability and can induce apoptosis in cancer cells. Increased PIAS3 expression is observed in various human cancers, suggesting its potential as a cancer biomarker.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • STAT3 signaling pathways are crucial in cell regulation.
  • PIAS3 (protein inhibitor of activated STAT3) inhibits STAT3 signaling.
  • PIAS3 regulates protein stability and function via SUMOylation.

Purpose of the Study:

  • To investigate the role of PIAS3 in cancer.
  • To determine if PIAS3 expression levels can serve as a cancer biomarker.

Main Methods:

  • Studied PIAS3's SUMO ligase activity.
  • Examined PIAS3's effect on prostate cancer cell lines (in vitro and in vivo).
  • Analyzed endogenous PIAS3 expression in human cancer specimens using immunohistochemistry.

Main Results:

  • PIAS3 overexpression induced apoptosis in prostate cancer cells.
  • Basal PIAS3 expression was detected in the nucleus of normal epithelial and endothelial cells.
  • Elevated PIAS3 expression was found in 100/103 human cancer samples, including lung, breast, prostate, colon-rectum, and brain tumors.

Conclusions:

  • PIAS3 plays a role in inducing apoptosis in cancer cells.
  • Differential PIAS3 expression patterns in cancer tissues may indicate its utility as a molecular marker for human cancers.